Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 12/20 | 0.37 |
| ▸ | KIF11 | P52732 | 3/20 | 0.34 |
| ▸ | PEPD | P12955 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5484141 | 0.82 | ADORA3 (0.37) | ALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL9450013 | 0.79 | KIF11 (0.37) | ALDH1A1NR3C2KIF11PEPDCYP3A4 | |
| SCHEMBL5480936 | 0.79 | NPC1 (0.40) | ALDH1A1NR3C2KIF11PEPDCYP3A4 | |
| SCHEMBL5476614 | 0.78 | HTT (0.44) | — | |
| SCHEMBL5484407 | 0.75 | ALDH1A1 (0.40) | ALDH1A1NR3C2KIF11PEPDHSD17B10 | |
| SCHEMBL15414817 | 0.72 | DGAT1 (0.32) | — | |
| SCHEMBL2067231 | 0.71 | — | — | |
| SCHEMBL5479979 | 0.69 | ALDH1A1 (0.41) | ALDH1A1NR3C2KIF11PEPDHSD17B10 | |
| SCHEMBL5480939 | 0.68 | NPC1 (0.40) | ALDH1A1NR3C2PEPDCYP3A4NPC1 | |
| SCHEMBL2068054 | 0.67 | F2RL1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208021-A1 | Phenoxyacetic Acid Derivatives and Drug Comprising The Same | DAIICHI PHARMACEUTICAL CO., LTD. | 2007-09-06 | — | — | US | disclosed |
| EP-1731513-A1 | PHENOXYACETIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208021-A1 | Phenoxyacetic Acid Derivatives and Drug Comprising The Same | PPARA, PPARG, PPARD | ALDH1A1 620/4885NR3C2 244/4885KIF11 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.